Translational Highlights in Breast and Ovarian Cancer 2019-Immunotherapy, DNA Repair, PI3K Inhibition and CDK4/6 Therapy

Hartkopf, Andreas D.; Mueller, Volkmar; Woeckel, Achim; Lux, Michael P.; Janni, Wolfgang; Ettl, Johannes; Belleville, Erik; Schuetz, Florian; Fasching, Peter A.; Kolberg, Hans-Christian; Welslau, Manfred; Overkamp, Friedrich; Taran, Florin-Andrei; Brucker, Sara Y.; Wallwiener, Markus; Tesch, Hans; Fehm, Tanja N.; Schneeweiss, Andreas; Lueftner, Diana

Erstveröffentlichung

2019

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Hartkopf, Andreas D.

Mueller, Volkmar

Woeckel, Achim

Lux, Michael P.

Janni, Wolfgang

et al.

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Published in

Geburtshilfe und Frauenheilkunde ; 79 (2019), 12. - S. 1309-1319. - ISSN 0016-5751. - eISSN 1438-8804

Link to publication

https://dx.doi.org/10.1055/a-1039-4458

Funding information

Hexal
PRAEGNANT network
Pfizer
Celgene
Daiichi Sankyo Company Limited
etc.

Keywords

advanced breast cancer; metastases; therapy; mutation testing; immunotherapy; PARP; CDK4/6; BRCA1/2; PD-L1; PATHOLOGICAL COMPLETE RESPONSE; TRASTUZUMAB; SURVIVAL; OLAPARIB; MUTATION; WOMEN

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record